BUB1 and leiomyosarcoma: Our observations about the proliferation effect in osteosarcoma and leiomyosarcoma cells by BUB1 activity inhibition allow us to propose this pharmacological intervention (mostly in combination with conventional therapeutic drugs for sarcomas as taxanes) not only for these two sarcomas but also for other types.